CAS: 5560-72-5; 3-(6,7,8,9,10,11-Hexahydro-5H-Cycloocta[b]Indol-5-yl)-N,N-Dimethylpropan-1-Amine

结构式图片

MSDS等安全信息

    上下游产品

    CAS号1556-09-8 溴代环辛烷 | CAS号369-57-3 四氟硼酸重氮苯盐 | CAS号109-54-6 3-氯-1-(N,N-二甲基)丙胺 | CAS号22793-63-1 6,7,8,9,10,11-六...

    合成工艺路线路线简述

      📜(6Z,10Z)-5-Tosyl-8,9-Dihydro-5H-Cycloocta[b]Indole置于乙醇,Palladium 10% On Activated Carbon,Potassium Tert-Butylate,氢气,四丁基碘化铵,Potassium Hydroxide体系中,用 乙酸乙酯,N,N-二甲基甲酰胺 作为反应溶剂,20.0~120.0 °C,1.01 Mpa 条件下,反应 87.5H,反应生成 伊普吲哚
      参考文献:将八元环安装到indoles上的一锅法
      标题:将八元环安装到indoles上的一锅法
      摘要:环融合:2-烯丙基-3-碘-1--1-甲苯磺酰基-1 H-吲哚与炔丙基溴的pd 0催化反应可得到二氢环辛八烯[B]吲哚(参见示意图; Ms =分子筛,Tfp = Tris(2−呋喃基膦,Ts = 4-甲苯甲磺酰基),并通过碳-碳偶合,[1,5]-氢迁移和电环化进行.新建立的方法用于有效地访问艾普琳.
      DOI:10.1002/anie.201202971

      海关参考信息

      专利信息


      专利号:US-7576211-B2
      优先权日:2004-09-30
      标题 :Synthesis of thienopyridinone compounds and related intermediates
      发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE
      权利人:EPIX DELAWARE INC
      摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

      专利号:US-2008214827-A1
      优先权日:2004-02-03
      标 题:Synthesis of Cyanoimino-Benzoimidazoles
      发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
      权利人:EURO CELTIQUE SA
      摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

      专利号:US-7309799-B2
      优先权日:2004-06-01
      标 题:Methods for the synthesis of milnacipran and congeners thereof
      发明人:BUCHWALD STEPHEN L; SWAGER TIMOTHY M; RARIY ROMAN V
      权利人:COLLEGIUM PHARMACEUTICAL INC
      摘要:One aspect of the present invention relates to methods for synthesizing milnacipran or congeners thereof. Another aspect of the present invention relates to asymmetric methods for synthesizing enantiomerically enriched milnacipran or congeners thereof. The present invention also relates to methods for synthesizing intermediates useful in the non-asymmetric or asymmetric methods for synthesizing enantiomerically enriched milnacipran or congeners thereof.

      专利号:CN-102675186-A
      优先权日:2012-05-24
      标 题 :Indolo eight-membered ring diene compound, its synthesis method and its application in the synthesis of iprindole

      专利号:CN-102675186-B
      优先权日:2012-05-24
      标题 :Indolo eight-membered ring diene compound, its synthesis method and its application in the synthesis of iprindole

      专利号:WO-2008084057-A1
      优先权日:2007-01-10
      标题:Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
      发明人:LANGE JOSEPHUS H M; KRUSE CORNELIS G
      权利人:SOLVAY PHARM BV; LANGE JOSEPHUS H M; KRUSE CORNELIS G
      摘要:This invention relates to compounds with a combination of cannabinoid-CB1antagonism and serotonin reuptake inhibition to pharmaceutical compositions containing these compounds, to methods for preparing the compounds, methods for preparing novel intermediates useful for their synthesis, and methods for preparing compositions. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in psychosis, anxiety, depression, attention deficits, cognitive disorders, obesity, drug dependence, Parkinson's disease, Alzheimer's disease, pain disorders, neuropathic pain disorders and sexual disorders. In particular the invention relates to compoundsof the general formula (I): wherein the symbols have the meanings given in the specification.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献

      1. Coutts RT, Hussain MS, Baker GB. Effect of iprindole on the metabolism of trimipramine in the rat. J Psychiatry Neurosci. 1991 Dec;16(5):272-5. 2. Baxter BL, Gluckman MI. Iprindole: an antidepressant which does not block REM sleep. Nature. 1969 Aug 16;223(5207):750-2. doi: 10.1038/223750a0.

      合成参考文献


      摘要:Psychotropic Drugs and Related Compounds, 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972, -(130), 1972
      摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
      参考文献:10.1016/0006-8993(80)91170-1
      摘要:Fuller RW, Molloy BB, Hemrick SK, Perry KW. Inhibition of rat brain norepinephrine N-methyltransferase by 2,3,4,5-tetrahydro-1H-indeno [1,2-c]pyridine hydrochloride (LY87130). Brain Res. 1980 May 19;190(1):215–23. doi: 10.1016/0006-8993(80)91170-1.
      参考文献:10.1016/0091-3057(95)02286-4
      摘要:Vogel G, Hagler M. Effects of neonatally administered iprindole on adult behaviors of rats. Pharmacology Biochemistry and Behavior. 1996 Sep;55(1):157–61. doi: 10.1016/0091-3057(95)02286-4.
      参考文献:10.1021/tx9501750
      摘要:Carvalho F, Remião F, Amado F, Domingues P, Correia AJ, Bastos ML. d-Amphetamine interaction with glutathione in freshly isolated rat hepatocytes. Chem Res Toxicol. 1996 Sep;9(6):1031–6. doi: 10.1021/tx9501750.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知